Nicolas Jouand

MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma

Virginie Vignard, Maureen Labbé, Nadège Marec et al. · Cancer Immunology Research · 2019 · 149 citations · Full text

The inhibitory receptor CD94/NKG2A on CD8+ tumor-infiltrating lymphocytes in colorectal cancer: a promising new druggable immune checkpoint in the context of HLAE/β2m overexpression

Juliette Eugène, Nicolas Jouand, Kathleen Ducoin et al. · Modern Pathology · 2019 · 74 citations · Full text

Tumor Biology, Cancer Immunosurveillance, Immunology +14

PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy

Sylvain Simon, Valentin Voillet, Virginie Vignard et al. · Journal for ImmunoTherapy of Cancer · 2020 · 68 citations · Full text

HCMV triggers frequent and persistent UL40-specific unconventional HLA-E-restricted CD8 T-cell responses with potential autologous and allogeneic peptide recognition

Nicolas Jouand, Céline Bressollette‐Bodin, Nathalie Gérard et al. · PLoS Pathogens · 2018 · 41 citations · Full text

Ul40 Peptide, Autoimmune Disease, Adaptive Immune System +14

CD40L confers helper functions to human intra-melanoma class-I-restricted CD4⁺CD8⁺double positive T cells

Tiphaine Parrot, Romain Oger, Houssem Benlalam et al. · OncoImmunology · 2016 · 16 citations · Full text